Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The value of survival gains in myelodysplastic syndromes.

    ... to the introduction of 3 novel therapies for myelodysplastic syndromes (MDS). STUDY DESIGN: Retrospective study of patients ...

    Research Article last updated 02/21/2017 - 11:36am.

  2. Stem and progenitor cell alterations in myelodysplastic syndromes

    ... Recent studies have demonstrated that myelodysplastic syndromes (MDS) arise from a small population of disease initiating ...

    Research Article last updated 02/21/2017 - 10:17am.

  3. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis

    ... binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic ...

    Research Article last updated 02/21/2017 - 10:33am.

  4. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... is a key survival prognostic factor in lower-risk myelodysplastic syndromes (MDS). Lenalidomide (LEN) can correct anemia in 25% of ...

    Research Article last updated 02/21/2017 - 9:43am.

  5. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.

    ... BACKGROUND: In myelodysplastic syndromes , thrombocytopenia is associated with mortality, but ...

    Research Article last updated 02/21/2017 - 9:49am.

  6. Myelodysplastic Syndromes Treatment (PDQ®): Patient Version

    ... summary has current information about the treatment of myelodysplastic syndromes . It is meant to inform and help patients, families, and ...

    Research Article last updated 12/02/2015 - 9:07am.

  7. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    ... 1, 2017 The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a ...

    Research Article last updated 02/01/2017 - 9:01am.

  8. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia

    ... 13, 2017 Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders of the elderly that ...

    Research Article last updated 02/01/2017 - 8:14am.

  9. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... effects of azacitidine in higher-risk myelodysplastic syndromes were established in mainly Caucasian populations. Because of ...

    Research Article last updated 02/03/2017 - 10:05am.

  10. Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 08/03/2017 - 9:15am.